Publications by authors named "M Lenihan"
Headguard use is appropriate during some combat sports activities where the risks of injury to the face and ears are elevated. Headguards are highly effective in reducing the incidence of facial lacerations in studies of amateur boxers and are just as effective in other striking sports. They should be used in scenarios - especially sparring prior to competitions - where avoidance of laceration and subsequent exposure to potential blood-borne pathogens is important.
View Article and Find Full Text PDFArticle Synopsis
- Intravenous immune globulin (IVIG) is a therapy being used for neuromuscular disorders, but there is limited high-quality evidence for many specific diseases, leading to the AANEM's 2009 consensus on its use.
- Since then, new research and FDA approvals have prompted an update to the guidelines, categorizing recommendations from Class I (strong evidence) to Class IV (weak evidence).
- IVIG is strongly recommended for conditions like chronic inflammatory demyelinating polyneuropathy and Guillain-Barré Syndrome but not recommended for others like inclusion body myositis, with uncertain support for various other disorders.
Background: The COVID-19 pandemic disrupted healthcare services worldwide, with a consequent impact on the delivery of medical education and training in all acute care specialties. Anaesthesia training has been challenged by a combination of reduced elective theatre activity, redeployment of trainees to critical care units, and changes in standard anaesthetic practices.
Methods: The aim of this study was to quantify the impact of COVID-19 on specialist anaesthesia training at a tertiary level teaching hospital in Ireland via a retrospective analysis of data captured by electronic anaesthesia records.
Background: Acute meningoencephalitis is encountered commonly in the acute hospital setting and is associated with significant morbidity and mortality, in addition to significant healthcare costs. Multiplex PCR panels now allow syndromic testing for central nervous system infection. The BioFire® FilmArray® Meningoencephalitis (ME) allows testing of 14 target pathogens using only 0.
View Article and Find Full Text PDF